Siemens Claims A First With Test That Can Quantify Neutralizing Antibodies To COVID-19
The test measures the relative level of antibodies, which could aid vaccine rollout.
You may also be interested in...
Siemens Healthineers Adds Muscle To Global Antibody Testing Effort, In Talks With Vaccine Developers
The company now has US emergency use designation for its new SARS-CoV-2 test, which can run on its global installed base of 20,000 analyzers at a current capacity of 50 million tests per month.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.